TherapeuticsMD (TXMD) EBT Margin (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly EBT Margin came in at 14.23% in Q1 2026, up 18420.0% YoY from N/an in Q1 2025, and up 121.9% on a QoQ basis from 64.95% in Q4 2025.
TherapeuticsMD (TXMD) EBT Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of EBT Margin data on file, last reported at 14.23% in Q1 2026.
- Quarterly EBT Margin rose 18420.0% year-over-year to 14.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 3.52% (up 12313.0% YoY) and the FY2025 annual result came in at 21.61%, up 11144.0% from the prior year.
- EBT Margin improved to 14.23% in Q1 2026, from 64.95% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 70.67% in Q4 2022 to a low of 4273.85% in Q2 2022.
- A 5-year average of 942.04% and a median of 258.47% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin plunged 408842 bps — and 2023, when it surged 372145 bps.
- Tracing TXMD's EBT Margin over 5 years: stood at 70.67% in 2022, then slumped by 578 bps to 337.74% in 2023, then surged by 104 bps to 12.44% in 2024, then sank by 622 bps to 64.95% in 2025, then surged by 122 bps to 14.23% in 2026.
- The last three EBT Margin figures came in at 14.23% (Q1 2026), 64.95% (Q4 2025), and 6.38% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 18.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.87% |
| Mar 31, 2026 | 14.23% |
| Dec 31, 2025 | -64.95% |
| Sep 30, 2025 | 6.38% |
| Jun 30, 2025 | 57.25% |
| Mar 31, 2025 | -169.97% |
| Dec 31, 2024 | 12.44% |
| Sep 30, 2024 | -103.66% |
| Jun 30, 2024 | -448.72% |
| Mar 31, 2024 | -258.47% |
| Dec 31, 2023 | -337.74% |
| Sep 30, 2023 | -2,705.66% |
| Jun 30, 2023 | -552.40% |
| Mar 31, 2023 | -555.29% |
| Dec 31, 2022 | 70.67% |
| Sep 30, 2022 | -4,133.05% |
| Jun 30, 2022 | -4,273.85% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | 268.50% |
| Sep 30, 2021 | -186.65% |